retatrutide type 2 diabetes phase 2 trial Weight loss with as compared to licenced obesity 🚨 BREAKING: Retatrutide Shows “Bariatric-Level”

Journal of Urology

This raises a critical question: do GLP-1 agonists have any direct effects (positive or negative) on hormone production or sperm parameters independent of weight loss

Acta Pharm Sin B 11 , 24492468

Nearly 70% of survey respondents expect a 2025 revenue increase and 71% expect a boost in profits

December 27, 2024: FDA Posts Updates to Zepbounds Drug Label to Include More Information About Acute Pancreatitis Due to results from two clinical trials for Zepbound, the FDA has posted drug safety-related labeling changes for the weight-loss drug

A mouse model of X-linked intellectual disability associated with impaired removal of histone methylation